Liaoning Chengda Biotechnology Co. Ltd.SSE: 688739

Report for Q1 2025

Apr 30, 2025 · Issued by Liaoning Chengda Biotechnology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 30, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-414

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Liaoning Chengda Biotechnology Co. Ltd. on 6ix

Earlier from Liaoning Chengda Biotechnology

Announcement on Convening Performance Briefing for 2024 and Q1 2025Apr 25, 2025
Notice on Convening the 2024 Annual General MeetingApr 24, 2025
Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public OfferingApr 19, 2025
Announcement on Completion of Share Delivery for Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.Apr 12, 2025
Announcement on Result of Tender Offer and Stock Resumption for Shaoguan Gaoteng Enterprise Management Co., Ltd.Apr 8, 2025

Later from Liaoning Chengda Biotechnology

Announcement on Resolution of the 2024 Annual General MeetingMay 15, 2025
Announcement on Implementation of Dividend Distribution of 2024Jun 4, 2025
Indicative Announcement on the Chairman's Proposal to Repurchase the Company's SharesJun 18, 2025
Announcement on Resolution of the 19th Meeting of the 5th Board of DirectorsJun 20, 2025
Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares RepurchaseJun 25, 2025

All Liaoning Chengda Biotechnology news releases

Follow Liaoning Chengda Biotechnology into a list and get an email when it puts out news.

Follow Liaoning Chengda Biotechnology